The Medical Imaging Convention London 2018

The importance of quantitative analysis in breast imaging was the focus of numerous abstracts accepted for presentation at the 103rd Annual Radiological Society of North America (RSNA) meeting, Nov. 26-Dec. 1 in Chicago. Four abstracts highlighted the use of Volpara Solutions' quantitative analysis tools for breast imaging. The tools provide actionable quantitative metrics for clinicians, including volumetric density, personalized dose, potential high risk, and other factors designed to maintain accuracy and drive consistent quality in breast screening.

ScImage Inc. introduced PicomPassport at the Radiological Society of North America’s 103rd Annual Scientific Assembly, Nov. 26-Dec. 1 in Chicago. PicomPassport is a new technology that leverages PICOM365’s Azure-based Cloud to simplify the importing of external patient exams into any picture archiving and communication system (PACS).

November 29, 2017 — Philips announced the introduction of IntelliSpace Enterprise Edition for Radiology, its comprehensive managed solution for enterprise imaging. By enhancing and optimizing workflows through adaptive intelligence and expert guidance tools, this new solution aims to empower radiologists to provide improved care.

November 28, 2017 — Hologic Inc. announced it has signed a development and distribution agreement with Clarius Mobile Health for its wireless, handheld ultrasound scanner. The announcement was made at the 2017 annual meeting of the Radiological Society of North America (RSNA), Nov. 26-Dec. 1 in Chicago. Financial terms of the agreement were not disclosed.

November 28, 2017 — Fujifilm Medical Systems U.S.A. Inc. displayed the all-new FDR Go Plus version portable digital radiography (DR) system among its suite of mobile DR solutions at the 103rd scientific assembly and annual meeting of the Radiological Society of North America (RSNA), Nov. 26-Dec. 1 in Chicago.

Hologic Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Quantra 2.2 Breast Density Assessment Software. The software enables clinicians to provide women with consistent breast density assessments during routine breast cancer screenings.Hologic Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Quantra 2.2 Breast Density Assessment Software. The software enables clinicians to provide women with consistent breast density assessments during routine breast cancer screenings.Hologic Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Quantra 2.2 Breast Density Assessment Software. The software enables clinicians to provide women with consistent breast density assessments during routine breast cancer screenings.

Hologic Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Quantra 2.2 Breast Density Assessment Software. The software enables clinicians to provide women with consistent breast density assessments during routine breast cancer screenings.

Head CT AI Augmented Screening

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now